Figure 2.
New chronic disease diagnoses among unique patients, National Patient-Centered Clinical Research Network (PCORnet) sites, 2018–2022. Percentages of patients newly diagnosed with breast cancer, cervical cancer, and cervical intraepithelial neoplasia or carcinoma in situ (CIN/CIS) are presented out of all women receiving care that year from participating PCORnet sites; percentages of patients diagnosed with all other conditions are presented out of all patients (men and women) receiving care that year from participating PCORnet sites. Cholesterol indicates initiation of a new cholesterol medication. Total unique patient counts by year: 2018: N = 12,262,754 overall, 7,264,953 women; 2019: N = 13,064,373 overall, 7,719,031 women; 2020: N = 13,402,584 overall, 7,849,336 women; 2021: N = 15,652,210 overall, 9,164,607 women; 2022: N = 15,506,288 overall, 9,128,281 women.
| Condition | 2018, % | 2019, % | 2020, % | 2021, % | 2022, % |
|---|---|---|---|---|---|
| Colonic adenoma | 1.06 | 1.03 | 0.85 | 0.97 | 1.10 |
| Cholesterol | 4.36 | 4.69 | 4.10 | 4.33 | 4.82 |
| Diabetes | 3.63 | 3.78 | 3.24 | 3.42 | 3.70 |
| Hypertension | 6.08 | 6.26 | 5.57 | 6.06 | 6.14 |
| Breast cancer | 0.47 | 0.47 | 0.43 | 0.44 | 0.46 |
| Lung cancer | 0.18 | 0.18 | 0.16 | 0.15 | 0.16 |
| Colorectal cancer | 0.14 | 0.14 | 0.13 | 0.13 | 0.14 |
| Cervical cancer | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 |
| CIN/CIS | 0.30 | 0.29 | 0.27 | 0.26 | 0.26 |
